ReviewDevelopmental biology2026
Receptor tyrosine kinase signaling in mammalian eye development.
Review in Developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Receptor tyrosine kinase (RTK) signaling is a central mechanism by which local tissue interactions are translated into coordinated morphogenesis during eye development. The vertebrate eye provides a uniquely tractable system for studying this logic because it is assembled from neural epithelium, surface ectoderm, neural crest-derived mesenchyme, vascular endothelium, and specialized epithelial and endothelial derivatives across a prolonged developmental timeline. In this review, we synthesize how major RTK families, including FGF-FGFR, EGF-ErbB, PDGF-PDGFR, VEGF-VEGFR, Eph-ephrin, ANGPT-TEK/Tie2, IGF-INS receptors, and collagen-sensing DDRs, control optic cup formation, optic fissure closure, lens differentiation and architecture, corneal and anterior segment morphogenesis, retinal vascularization, Schlemm's canal development, and lacrimal gland branching. Rather than acting through pathway-specific outputs, these receptors repeatedly converge on shared MAPK/ERK, PI3K-AKT, PLCγ-PKC, SRC/FAK, and Rho-family cytoskeletal modules. Developmental specificity emerges from ligand geography, receptor dosage, co-receptor and extracellular matrix context, signal duration, receptor trafficking, mechanical state, and cross-talk with other signaling pathways. We also highlight how emerging single-cell, spatial, and multiomic atlases are shifting the field from static expression maps toward ligand-receptor source mapping and quantitative pathway-state inference. Finally, we connect developmental RTK mechanisms to congenital and pediatric eye disease. Together, these studies position the eye as a powerful model for understanding how reiterative RTK signaling builds complex organ form and informs therapeutic modulation, regenerative medicine, and disease mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.